Radiation therapy is one of the most common treatment strategies for thorax malignancies. One of the considerable limitations of this therapy is its toxicity to normal tissue. The lung is the major dose-limiting organ for radiotherapy. That is because ionizing radiation produces reactive oxygen species that induce lesions, and not only is tumor tissue damaged, but overwhelming inflammatory lung damage can occur in the alveolar epithelium and capillary endothelium. This damage may result in radiation-induced pneumonitis and/or fibrosis. While describing the lung response to irradiation generally, the main focus of this review is on cytokines and their roles and functions within the individual stages. We discuss the relationship between radiation and cytokines and their direct and indirect effects on the formation and development of radiation injuries. Although this topic has been intensively studied and discussed for years, we still do not completely understand the roles of cytokines. Experimental data on cytokine involvement are fragmented across a large number of experimental studies; hence, the need for this review of the current knowledge. Cytokines are considered not only as molecular factors involved in the signaling network in pathological processes, but also for their diagnostic potential. A concentrated effort has been made to identify the significant immune system proteins showing positive correlation between serum levels and tissue damages. Elucidating the correlations between the extent and nature of radiation-induced pulmonary injuries and the levels of one or more key cytokines that initiate and control those damages may improve the efficacy of radiotherapy in cancer treatment and ultimately the well-being of patients.
- MeSH
- chemokiny škodlivé účinky MeSH
- cytokiny škodlivé účinky MeSH
- lidé MeSH
- plíce patologie účinky záření MeSH
- poškození plic chemicky indukované patologie MeSH
- radiační poranění chemicky indukované MeSH
- receptory chemokinů metabolismus MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The increasing risk of acute large-scale radiological/nuclear exposures of population underlines the necessity of developing new, rapid and high throughput biodosimetric tools for estimation of received dose and initial triage. We aimed to compare the induction and persistence of different radiation exposure biomarkers in human peripheral blood in vivo. Blood samples of patients with indicated radiotherapy (RT) undergoing partial body irradiation (PBI) were obtained soon before the first treatment and then after 24 h, 48 h, and 5 weeks; i.e. after 1, 2, and 25 fractionated RT procedures. We collected circulating peripheral blood from ten patients with tumor of endometrium (1.8 Gy per fraction) and eight patients with tumor of head and neck (2.0-2.121 Gy per fraction). Incidence of dicentrics and micronuclei was monitored as well as determination of apoptosis and the transcription level of selected radiation-responsive genes. Since mitochondrial DNA (mtDNA) has been reported to be a potential indicator of radiation damage in vitro, we also assessed mtDNA content and deletions by novel multiplex quantitative PCR. Cytogenetic data confirmed linear dose-dependent increase in dicentrics (p < 0.01) and micronuclei (p < 0.001) in peripheral blood mononuclear cells after PBI. Significant up-regulations of five previously identified transcriptional biomarkers of radiation exposure (PHPT1, CCNG1, CDKN1A, GADD45, and SESN1) were also found (p < 0.01). No statistical change in mtDNA deletion levels was detected; however, our data indicate that the total mtDNA content decreased with increasing number of RT fractions. Interestingly, the number of micronuclei appears to correlate with late radiation toxicity (r2 = 0.9025) in endometrial patients suggesting the possibility of predicting the severity of RT-related toxicity by monitoring this parameter. Overall, these data represent, to our best knowledge, the first study providing a multiparametric comparison of radiation biomarkers in human blood in vivo, which have potential for improving biological dosimetry.
- MeSH
- biologické markery krev MeSH
- celková dávka radioterapie MeSH
- chromozomální aberace MeSH
- genetická transkripce účinky záření MeSH
- leukocyty patologie účinky záření MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikrojádra chromozomálně defektní MeSH
- mitochondriální DNA účinky záření MeSH
- nádory endometria krev radioterapie MeSH
- nádory hlavy a krku krev radioterapie MeSH
- radiační expozice * MeSH
- radiometrie metody MeSH
- radioterapie škodlivé účinky MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- vztah dávky záření a odpovědi MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- srovnávací studie MeSH
This review summarizes recent progress in understanding the role of p53-upregulated mediator of apoptosis (PUMA) in molecular pathways with respect to its potential therapeutic applications. Particular emphasis is given to the PUMA´s role in ionizing radiation-induced signalling as radiotoxicity of normal tissue is mediated mostly via apoptosis. PUMA and its p53-dependent and p53- independent induction are described and potential use as a new target for the development of radioprotective agents is suggested. Further implications, including targeting PUMA to prevent and treat cardiovascular and neurodegenerative diseases, are also discussed together with an overview of other therapeutic applications. Finally, basic chemical structures for the development of novel PUMA modulators such as pifithrine derivatives, kinase inhibitors or modulators of Bcl-2 protein family are described.
- MeSH
- apoptóza účinky léků genetika MeSH
- cílená molekulární terapie metody MeSH
- kardiovaskulární látky farmakologie terapeutické užití MeSH
- kardiovaskulární nemoci farmakoterapie patologie MeSH
- lidé MeSH
- nádorový supresorový protein p53 antagonisté a inhibitory genetika metabolismus MeSH
- nádory genetika radioterapie MeSH
- neurodegenerativní nemoci farmakoterapie patologie MeSH
- neuroprotektivní látky farmakologie terapeutické užití MeSH
- poškození DNA účinky léků účinky záření MeSH
- proteiny regulující apoptózu antagonisté a inhibitory metabolismus MeSH
- protoonkogenní proteiny antagonisté a inhibitory metabolismus MeSH
- radiační poranění prevence a kontrola MeSH
- radioprotektivní látky farmakologie terapeutické užití MeSH
- signální transdukce účinky léků genetika MeSH
- tolerance záření účinky léků MeSH
- vazba proteinů účinky léků MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Here, we compared the effects of inhibitors of three phosphatidylinositol-3-kinase-related kinases, ATM, ATR a DNA-PK, on radiosensitization of cervical carcinoma cells. We demonstrated that DNA-PK inhibitor NU7441 enhanced phosphorylation of Chk1 and Chk2 kinases 2 h after irradiation of HeLa cells at a dose of 8 Gy in contrast to ATM kinase inhibitor KU55933, which completely blocked the Chk2 kinase phosphorylation on threonine 68, and ATR kinase inhibitor VE-821, which blocked the Chk1 kinase phosphorylation on serine 345. Most HeLa cells were accumulated in G2 phase of the cell cycle 24 h after irradiation at a high dose of 15 Gy, which was even potentiated after adding the inhibitors NU7441 and KU55933. Compared to all other irradiated groups, inhibitor VE-821 increased the number of cells in S phase and reduced the number of cells in G2 phase 24 h after irradiation at the high dose of 15 Gy. HeLa cells entered the mitotic cycle with unrepaired DNA, which resulted in cell death and the radiosensitizing effect of VE-821. Short-term application of the inhibitors (2 h before and 30 min after the irradiation by the dose of 8 Gy) significantly decreased the colony-forming ability of HeLa cells. Using real-time monitoring of cell proliferation by the xCELLigence system we demonstrated that while the radiosensitizing effect of VE-821 (ATR inhibitor) is manifested early after the irradiation, the radiosensitizing effect of KU55933 (ATM inhibitor) and NU7441 (DNA-PK inhibitor) is only observed as late as 72 h after the irradiation.
- MeSH
- ATM protein antagonisté a inhibitory metabolismus MeSH
- buněčné klony MeSH
- buněčný cyklus účinky léků MeSH
- HeLa buňky MeSH
- inhibitory proteinkinas farmakologie MeSH
- lidé MeSH
- nádory děložního čípku enzymologie patologie MeSH
- počet buněk MeSH
- proliferace buněk účinky léků MeSH
- proteinkinasa aktivovaná DNA antagonisté a inhibitory metabolismus MeSH
- radiosenzibilizující látky farmakologie MeSH
- viabilita buněk účinky léků MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- srovnávací studie MeSH
We evaluated the impact of ataxia-telangiectasia mutated kinase inhibitor KU55933, DNA-dependent protein kinase inhibitor NU7441 and ataxia telangiectasia and rad3-related kinase inhibitor VE821 in human peripheral lymphocytes in vitro. The lymphocytes were divided into 5 groups: non-irradiated control, irradiated group (2 Gy) and 3 groups pretreated with inhibitors 30 min before irradiation. We used flow cytometry to evaluate phosphorylated H2AX (γ-H2AX) and cytotoxicity (Apoptest). Micronucleus assay was used to assess genotoxicity. After irradiation, γ-H2AX, incidence of micronuclei (MN), nucleoplasmatic bridges (NPBs) and nuclear buds in binuclear cells, MN in mononuclear cells and apoptosis were increased. KU55933 decreased γ-H2AX and inhibited ionizing radiation-induced cytotoxicity. NU7441 showed no effect on γ-H2AX but it significantly increased MN and NPBs in binuclear cells and apoptosis. VE821 decreased γ-H2AX, whereas genotoxicity and cytotoxicity were not affected. In conclusion, KU55933 protected lymphocytes, which might be employed to preserve the immune system during anticancer therapy. NU7441 radiosensitized lymphocytes, thus, undesirable side effects toward immune system could be expected. VE821 showed decrease of γ-H2AX with no radiosensitizing effects in our model likely due to p53 positive status, which underlies the concept of its application in p53 negative environment.
- Klíčová slova
- Účinky ionizujícího záření způsobené inhibitory ATM (KU55933), DNA-PK (NU7441) a ATR (VE821) na lymfocyty periferní krve,
- MeSH
- ATM protein účinky záření MeSH
- biomedicínský výzkum MeSH
- financování organizované MeSH
- fosfatidylinositol-3-kinasy účinky záření MeSH
- fosforylace imunologie účinky záření MeSH
- histony chemie účinky záření MeSH
- inhibitory fosfoinositid-3-kinasy MeSH
- ionizující záření * MeSH
- krevní a imunitní systémy cytologie imunologie účinky záření MeSH
- lidé MeSH
- lymfocyty * cytologie imunologie účinky záření MeSH
- statistika jako téma MeSH
- techniky in vitro MeSH
- Check Tag
- lidé MeSH
- MeSH
- antigeny CD27 účinky záření MeSH
- B-lymfocyty * účinky záření MeSH
- celková dávka radioterapie MeSH
- dávka záření * MeSH
- fosforylace MeSH
- frakcionace dávky záření MeSH
- histony MeSH
- imunoglobulin M účinky záření MeSH
- imunoglobulinové izotypy účinky záření MeSH
- ionizující záření MeSH
- klinické protokoly normy MeSH
- lidé MeSH
- modely u zvířat MeSH
- prasata krev MeSH
- průtoková cytometrie * MeSH
- radiometrie MeSH
- referenční standardy MeSH
- T-lymfocyty účinky záření MeSH
- tolerance záření MeSH
- ukládání a vyhledávání informací MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- práce podpořená grantem MeSH
Francisella tularensis, a facultative intracellular Gram-negative bacterium, causes the illness tularemia. The infection of mice with live vaccine strain is considered to be a model of human tularemia. F. tularensis infects predominantly such phagocytic cells as macrophages or neutrophils, but it also infects non-phagocytic hepatocytes, epithelial cells, and murine and human B cell lines. Based on work with the murine tularemia model, we report here that F. tularensis LVS infects peritoneal CD19(+) cells - exclusively B-1a cells - early after intraperitoneal infection in vivo. The peritoneal and consequently spleen CD19(+) cells are activated by the F. tularensis LVS infection to express the activation markers from MHC class II, CD25, CD54, CD69, and the co-stimulatory molecules CD80 and CD86. As early as 12 h post-infection, the peritoneal CD19(+) cells produce IFN-γ, IL-1β, IL-4, IL-6, IL-12, IL-17, IL-23, and TNF-α. The spleen CD19(+) cells respond to infection with some delay. Moreover, the F. tularensis infected A20 B cell line activates CD3(+) spleen cells isolated from naïve mice. Thus, the data presented here suggest that B cells have all the attributes to actively participate in the induction and regulation of the adaptive immune response during early stages of F. tularensis infection.
- MeSH
- aktivace lymfocytů * MeSH
- časové faktory MeSH
- CD antigeny analýza MeSH
- cytokiny sekrece MeSH
- MHC antigeny II. třídy analýza MeSH
- modely nemocí na zvířatech MeSH
- myši inbrední BALB C MeSH
- peritoneum imunologie MeSH
- podskupiny B-lymfocytů chemie imunologie MeSH
- slezina imunologie MeSH
- tularemie imunologie MeSH
- zvířata MeSH
- Check Tag
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
